RLUN20039, Chen, S1827, Extensive Stage Lung Small Cell Carcinoma, Prophylactic Cranial
Irradiation
Research Question:
Studies magnetic resonance imaging (MRI) surveillance and prophylactic cranial irradiation
(PCI) to see how well they work compared to MRI surveillance alone in treating patients
with small cell lung cancer.
Basic Study Information
Purpose:
This phase III trial studies magnetic resonance imaging (MRI) surveillance and prophylactic
cranial irradiation (PCI) to see how well they work compared to MRI surveillance alone
in treating patients with small cell lung cancer. MRI scans are used to monitor the
possible spread of the cancer with an MRI machine over time. PCI is radiation therapy
that is delivered to the brain in hopes of preventing spread of cancer into the brain.
The use of brain MRI alone may reduce side effects of receiving PCI and prolong patients'
lifespan. Monitoring with MRI scans alone (delaying radiation until the actual spread
of the cancer) may be at least as good as the combination of PCI with MRI scans.
Location: University of Rochester James P. Wilmot Cancer Institute
Study Reference #: RLUN20039
Lead Researcher (Principal Investigator)
Lead Researcher:
Yuhchyau Chen
Study Contact Information
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search